Elongation factor for RNA polymerase II 2 pseudogene 3 (ELL2P3)

Elongation factor for RNA polymerase II 2 pseudogene 3 (ELL2P3) is annotated as a pseudogene in the human genome and does not encode a functional protein[1][3][7][9][11]. Pseudogenes arise from duplication or mutation events that render the sequence unable to produce a functional protein product. Unlike the parent gene ELL2, which is part of the transcription elongation complex for RNA polymerase II and is involved in transcriptional regulation, ELL2P3 has not been demonstrated to encode a functional elongation factor, nor is there evidence it participates in canonical biological processes or disease mechanisms[4][7][9]. Pseudogenes may sometimes produce RNA transcripts, but these are generally noncoding and rarely have established biological or therapeutic relevance[8]. There are no known drugs or therapeutic agents targeting ELL2P3, and it is not considered a druggable or mechanistically relevant target for disease[7][11]. **Note:** - ELL2P3 is a pseudogene, not an active protein-coding gene or established therapeutic target. - Inclusion in lists of "targets" for drug discovery, molecular pharmacology, or related purposes is incorrect. - Generally, pseudogenes are not considered in assessments of molecular mechanisms or as clinical biomarkers unless they have specialized, experimentally validated noncoding RNA functions, which is not established for ELL2P3 as of current knowledge[8][9][11].

Other names

elongation factor, RNA polymerase II, 2 pseudogene 3elongation factor for RNA polymerase II 2 pseudogene 3ELL2P3